Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hasan Rajabi

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Cancer Research|December 22, 2017
MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast CancerTakahiro Maeda, Masayuki Hiraki, Caining Jin, et al.
Cancer Research|March 3, 2019
MUC1-C Integrates Chromatin Remodeling and PARP1 Activity in the DNA Damage Response of Triple-Negative Breast Cancer CellsMasaaki Yamamoto, Caining Jin, Tsuyoshi Hata, et al.
Acta Medica Iranica|March 22, 2015
Evaluation of effective factors in success rate of intervention on CTOMohammadhasan Namazi, Morteza Safi, Hosein Vakili, et al.
Molecular Cancer Research : MCR|January 13, 2022
MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem CellsAtrayee Bhattacharya, Atsushi Fushimi, Nami Yamashita, et al.
Molecular Cancer Therapeutics|July 17, 2019
Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast CancerTsuyoshi Hata, Hasan Rajabi, Masaaki Yamamoto, et al.
JCI Insight|May 20, 2020
MUC1-C drives stemness in progression of colitis to colorectal cancerWei Li, Ning Zhang, Caining Jin, et al.
Molecular Cancer Research : MCR|May 25, 2022
Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non-neuroendocrine Small Cell Lung CancerAtsushi Fushimi, Yoshihiro Morimoto, Satoshi Ishikawa, et al.
Journal of Neuroinflammation|December 31, 2015
Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulationMaria Antonietta Mazzola, Radhika Raheja, Gopal Murugaiyan, et al.
Blood|June 7, 2015
Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphomaSalvia Jain, Dina Stroopinsky, Li Yin, et al.
Cancer Research|September 15, 2019
MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer CellsTsuyoshi Hata, Hasan Rajabi, Hidekazu Takahashi, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Cancer Research|December 22, 2017
MUC1-C Induces PD-L1 and Immune Evasion in Triple-Negative Breast CancerTakahiro Maeda, Masayuki Hiraki, Caining Jin, et al.
Cancer Research|March 3, 2019
MUC1-C Integrates Chromatin Remodeling and PARP1 Activity in the DNA Damage Response of Triple-Negative Breast Cancer CellsMasaaki Yamamoto, Caining Jin, Tsuyoshi Hata, et al.
Acta Medica Iranica|March 22, 2015
Evaluation of effective factors in success rate of intervention on CTOMohammadhasan Namazi, Morteza Safi, Hosein Vakili, et al.
Molecular Cancer Research : MCR|January 13, 2022
MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem CellsAtrayee Bhattacharya, Atsushi Fushimi, Nami Yamashita, et al.
Molecular Cancer Therapeutics|July 17, 2019
Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast CancerTsuyoshi Hata, Hasan Rajabi, Masaaki Yamamoto, et al.
JCI Insight|May 20, 2020
MUC1-C drives stemness in progression of colitis to colorectal cancerWei Li, Ning Zhang, Caining Jin, et al.
Molecular Cancer Research : MCR|May 25, 2022
Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non-neuroendocrine Small Cell Lung CancerAtsushi Fushimi, Yoshihiro Morimoto, Satoshi Ishikawa, et al.
Journal of Neuroinflammation|December 31, 2015
Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulationMaria Antonietta Mazzola, Radhika Raheja, Gopal Murugaiyan, et al.
Blood|June 7, 2015
Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphomaSalvia Jain, Dina Stroopinsky, Li Yin, et al.
Cancer Research|September 15, 2019
MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer CellsTsuyoshi Hata, Hasan Rajabi, Hidekazu Takahashi, et al.
Pageof 6